ADMdx
Curated by SignalNeuroimaging diagnostic software for Alzheimer's disease and other dementias
Overview
Neuroimaging diagnostic software for Alzheimer's disease and other dementias. Its proprietary imaging algorithm uses multivariate analysis algorithms to characterize brain metabolism patterns in five stages ranging from mild cognitive impairment to full-blown Alzheimer's disease, and machine learning to differentiate between different types of dementia. The company also licenses a patent from NYU for precise measurement of hippocampal volume. ADMDx currently uses its software for drug development studies but plans to expand to clinical diagnostics. In addition, it also provides other imaging services in all stages of clinical trials for neurological disorders, ranging from preclinical to pivotal phase III. Contract research services include study design, protocol development, site selection, and qualification, imaging charter and acquisition manual development, study start-up, site management, data management, and quality control, image processing and analysis, comparisons to reference data, study closeout, reporting, and data archiving.
Key facts
- Founded
- 2010
- Headquarters
- Northbrook, United States
- Stage
- Sign up to view
- Industry
- Health Technology
Business model
- 3 products and services
- Sign up to view
Contact
- Primary office
- Sign up to view
- Sign up to view